Thomas W. Dubensky - 18 Aug 2022 Form 4 Insider Report for HTG MOLECULAR DIAGNOSTICS, INC

Role
Director
Signature
/s/ Shaun D. McMeans, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Aug 2022
Net transactions value
$0
Form type
4
Filing time
22 Aug 2022, 17:27:24 UTC
Previous filing
22 Jun 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HTGMQ Stock Option (right to buy) Award $0 +8,000 $0.000000 8,000 18 Aug 2022 Common Stock 8,000 $0.9400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares will vest twelve months after August 18, 2022 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of August 18, 2022.